These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24341887)

  • 41. Chapter eight--Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans.
    Cerullo V; Koski A; Vähä-Koskela M; Hemminki A
    Adv Cancer Res; 2012; 115():265-318. PubMed ID: 23021247
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
    Udagawa M; Kudo-Saito C; Hasegawa G; Yano K; Yamamoto A; Yaguchi M; Toda M; Azuma I; Iwai T; Kawakami Y
    Clin Cancer Res; 2006 Dec; 12(24):7465-75. PubMed ID: 17189420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials.
    Mossoba ME; Medin JA
    Expert Rev Vaccines; 2006 Oct; 5(5):717-32. PubMed ID: 17181444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Roadmap to a better therapeutic tumor vaccine.
    Emens LA
    Int Rev Immunol; 2006; 25(5-6):415-43. PubMed ID: 17169782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer immunotherapy.
    Baxevanis CN; Perez SA; Papamichail M
    Crit Rev Clin Lab Sci; 2009; 46(4):167-89. PubMed ID: 19650714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Telomerase, a universal target in immunotherapy strategies against tumor?].
    Rousseau R; Soria JC
    Bull Cancer; 2000 Dec; 87(12):895-901. PubMed ID: 11174119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The cyclins: a family of widely expressed tumor antigens?
    von Bergwelt-Baildon MS; Kondo E; Klein-González N; Wendtner CM
    Expert Rev Vaccines; 2011 Mar; 10(3):389-95. PubMed ID: 21434806
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo destruction of tumor tissue by cryoablation can induce inhibition of secondary tumor growth: an experimental study.
    Joosten JJ; Muijen GN; Wobbes T; Ruers TJ
    Cryobiology; 2001 Feb; 42(1):49-58. PubMed ID: 11336489
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dendritic cell immunotherapy in soft tissue sarcoma.
    Indelicato DJ; Finkelstein SE
    Immunotherapy; 2012 Oct; 4(10):1023-9. PubMed ID: 23148754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent developments in therapeutic cancer vaccines.
    Morse MA; Chui S; Hobeika A; Lyerly HK; Clay T
    Nat Clin Pract Oncol; 2005 Feb; 2(2):108-13. PubMed ID: 16264883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adoptive immunotherapy of breast cancer with lymph node cells primed by cryoablation of the primary tumor.
    Sabel MS; Arora A; Su G; Chang AE
    Cryobiology; 2006 Dec; 53(3):360-6. PubMed ID: 16973145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Universal and stemness-related tumor antigens: potential use in cancer immunotherapy.
    Parmiani G; Russo V; Marrari A; Cutolo G; Casati C; Pilla L; Maccalli C; Rivoltini L; Castelli C
    Clin Cancer Res; 2007 Oct; 13(19):5675-9. PubMed ID: 17908956
    [No Abstract]   [Full Text] [Related]  

  • 53. [Dendritic cells and their applications in cancer immunotherapy--achievements and future prospects].
    Rossowska J; Pajtasz-Piasecka E
    Postepy Hig Med Dosw; 2003; 57(5):501-18. PubMed ID: 14737967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cryoablation reshapes the immune microenvironment in the distal tumor and enhances the anti-tumor immunity.
    Wu Y; Cao F; Zhou D; Chen S; Qi H; Huang T; Tan H; Shen L; Fan W
    Front Immunol; 2022; 13():930461. PubMed ID: 36119081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immunology: new approaches to immuno-modulation and immunotherapy].
    Kabelitz D
    Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1471-3. PubMed ID: 16794979
    [No Abstract]   [Full Text] [Related]  

  • 57. Dendritic cell based immunotherapy--a promising therapeutic approach for endocrine malignancies.
    Sbiera S; Wortmann S; Fassnacht M
    Horm Metab Res; 2008 Feb; 40(2):89-98. PubMed ID: 18283626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cancer and the immune system.
    Smith RT
    Pediatr Clin North Am; 1994 Aug; 41(4):841-50. PubMed ID: 8047372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
    Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
    Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combinations Therapies.
    Reinmuth N; Reck M
    Prog Tumor Res; 2015; 42():79-94. PubMed ID: 26384009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.